Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,164.80
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
2,090.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,164.80
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
2,090.82
Raw Material Cost
623.69
692.45
729.53
754.57
727.57
695.09
771.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.33
5.44
7.28
7.32
12.45
1.07
10.15
Selling and Distribution Expenses
869.55
788.73
827.21
857.10
799.00
861.12
811.19
Other Expenses
18.83
9.94
17.59
10.69
16.50
23.56
15.56
Total Expenditure (Excl Depreciation)
1,684.86
1,586.06
1,739.88
1,725.92
1,704.00
1,792.84
1,748.31
Operating Profit (PBDIT) excl Other Income
479.90000000000003
339.7
282.6
507.40000000000003
350.90000000000003
242.7
342.5
Other Income
19.45
52.84
49.52
32.66
66.37
50.30
44.06
Operating Profit (PBDIT)
472.36
366.60
421.18
613.18
503.74
188.86
443.33
Interest
3.33
5.44
7.28
7.32
12.45
1.07
10.15
Exceptional Items
14.92
130.75
-14.38
35.43
42.18
42.58
-83.90
Gross Profit (PBDT)
1,541.11
1,233.35
1,292.93
1,478.76
1,327.32
1,340.49
1,319.43
Depreciation
0.00
118.92
118.92
113.38
113.38
124.30
124.30
Profit Before Tax
483.95
372.99
280.60
527.90
420.08
106.06
224.98
Tax
96.97
123.68
45.36
38.97
75.88
41.21
28.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
370.24
120.59
209.68
460.39
314.31
113.38
179.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
370.24
120.59
209.68
460.39
314.31
113.38
179.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.69
-51.80
-6.90
-2.70
17.78
-82.47
-4.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
364.55
68.78
202.77
457.69
332.08
30.91
175.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,768.02
12,404.23
12,304.42
12,377.39
11,919.98
11,903.33
12,706.97
Earnings per share (EPS)
0.25
0.08
0.14
0.31
0.21
0.08
0.12
Diluted Earnings per share
0.25
0.08
0.14
0.31
0.21
0.08
0.12
Operating Profit Margin (Excl OI)
20.92%
10.12%
12.5%
20.92%
15.77%
0.7%
13.15%
Gross Profit Margin
22.36%
25.54%
19.75%
28.71%
25.96%
11.32%
16.71%
PAT Margin
17.1%
6.26%
10.37%
20.61%
15.3%
5.57%
8.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 12.41% vs -4.78% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 429.94% vs -66.07% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 44.33% vs -15.58% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -38.89% vs -26.03% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Tasly Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
2,164.80
0
2,164.80
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,164.80
0
2,164.80
Raw Material Cost
623.69
0
623.69
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.33
0
3.33
Selling and Distribution Expenses
869.55
0
869.55
Other Expenses
18.83
0.00
18.83
Total Expenditure (Excl Depreciation)
1,684.86
0
1,684.86
Operating Profit (PBDIT) excl Other Income
479.93
0.00
479.93
Other Income
19.45
0
19.45
Operating Profit (PBDIT)
472.36
0
472.36
Interest
3.33
0
3.33
Exceptional Items
14.92
0
14.92
Gross Profit (PBDT)
1,541.11
0
1,541.11
Depreciation
0.00
0
0.00
Profit Before Tax
483.95
0
483.95
Tax
96.97
0
96.97
Provisions and contingencies
0
0
0.00
Profit After Tax
370.24
0
370.24
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
370.24
0
370.24
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.69
0
-5.69
Other related items
0.00
0.00
0.00
Consolidated Net Profit
364.55
0
364.55
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,768.02
0
12,768.02
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
20.92%
0%
0.00
20.92%
Gross Profit Margin
22.36%
0%
0.00
22.36%
PAT Margin
17.10%
0%
0.00
17.10%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 216.48 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 12.41% vs -4.78% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 5.35% vs 0.30% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 36.46 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 429.94% vs -66.07% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.79% vs 13.34% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.29 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 44.33% vs -15.58% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.54% vs -14.08% in Mar 2025
Quarterly - Interest
Interest 0.33 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -38.89% vs -26.03% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -73.60% vs -58.75% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.92%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
